First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes

Posted on: May 14, 2022 | Posted by: Health Mag

The FDA approved first-in-class tirzepatide for patients with type 2 diabetes, the agency announced on Friday. Tirzepatide, a glucagon-like peptide-1 and glucose-dependent...

Other Posts from Health Mag

Roger Tuivasa-Sheck's crucial try-saver for the Blues
An 11-year-old girl thought she had a headache but it was a brain tumour
Week 1 Pregnancy Symptoms: What happens?
Kozzie finishes off smooth Dees move
Tassie taskforce seeking ‘robust' support: Club presidents to be invited to Apple Isle
Sri Lanka's protesters stay in the streets
Passionate environmental campaigner
Experts Attempt to Demystify Paxlovid Prescribing
Subjective Cognitive Decline in Adults Tied to Modifiable Risks
Labor pledges new environment agency, says Brisbane-based shadow minister
The 35 medical conditions GPs in England will no longer prescribe for as Welsh Government sets out its position
Covid cases in Wales fall dramatically
CDC: Monkeypox May Present With Genital Sores, No Prior Fever
Draft Genome Sequence of Latest Monkeypox Virus Unveiled
Nearly half of Americans report greater stress sensitivity with pandemic
Doja Cat Cancels Upcoming Summer Tour Dates Because of Tonsil Surgery, Vows to “Quit the Vape for a While”
Children with same-sex parents are socially well-adjusted
Getting on a bit? It's time for us to embrace 50 or more shades of grey
Government claims DHS disinfo board is being shut down because of disinfo
Monkeypox patients could be infectious for up to FOUR WEEKS after symptoms appear, experts say